Search Results

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic bre... by Bischoff, Joachim (Author) , Barinoff, Jana (Author) , Mundhenke, Christoph (Author) , Bauerschlag, Dirk Olaf (Author) , Costa, Serban-Dan (Author) , Herr, Daniel (Author) , Lübbe, Kristina (Author) , Marmé, Frederik (Author) , Maass, Nicolai (Author) , Minckwitz, Gunter von (Author) , Grischke, Eva-Maria (Author) , Müller, Volkmar (Author) , Schmidt, Marcus (Author) , Gerber, Bernd (Author) , Kümmel, Sherko (Author) , Schumacher, Claudia (Author) , Krabisch, Petra (Author) , Seiler, Sabine (Author) , Thill, Marc (Author) , Nekljudova, Valentina (Author) , Loibl, Sibylle (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    IGF1R as druggable target mediating PI3K-delta inhibitor resistance in a murine model of chronic lymphocytic leukemia by Scheffold, Annika (Author) , Dietrich, Sascha (Author) ,


    Get full text
    Article (Journal) Online Resource